Pharmaceuticals
Asia-Pacific DNA Vaccine Market Size, Share, Growth, Research and Forecast 2019-2025
The Asia-Pacific DNA Vaccine market is anticipated to grow at a CAGR 42.3% during the forecast period. Asia-Pacific has the significant market of DNA vaccine due to increasing awareness about the benefits and flexibility offered by DNA vaccines. Major economies contributing in the market are China, Japan, India, South Korea and Thailand. Factors such as growing prevalence of cancer, unhealthy lifestyle, increasing disposable income, increasing awareness among people toward vaccination are the major factors that are motivating the market. Some of the key players contributing in the growth of DNA vaccine market include Bharat Biotech, Geneone Life Sciences Inc., LG Life sciences and among others.
A full report of Asia-Pacific DNA Vaccine Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-dna-vaccines-market
The market is segmented on the basis of type, application and technology. Based on type, the market is segmented into animal DNA vaccine and human DNA vaccine. Based on technology, the market is segmented into plasmid DNA vaccine and plasmid DNA delivery. Based on application, the market is segmented into oncology, infectious disease and others.
Further, the Asia-Pacific market is analyzed on the basis of the countries that are contributing significantly towards the growth of the market. The Asia-Pacific market is further bifurcated into the China, India, Japan and Rest of Asia-Pacific. The market in China is estimated to be dominating and India is the fastest growing Asian country during the forecast period.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-dna-vaccines-market
The key market players that are active in the market includes Asteel Pharma Inc., Bharat Biotech Ltd., Eli Lilly and Co., GE Healthcare, Glaxosmithkline PLC., Indian Immunologicals Ltd., Merck & Co., Pfizer Inc., Roche Diagnostics GMBH and Serum Institute of India Pvt. Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
Asia-Pacific DNA Vaccine Market- Segmentation
by Type
- Animal DNA Vaccine
- Human DNA Vaccine
by Technology
- Plasmid DNA Vaccine
- Plasmid DNA Delivery
by Application
- Oncology
- Infectious Disease
- Others
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/asia-pacific-dna-vaccines-market
Asia-Pacific DNA Vaccine Market– Segment by Region
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
Company Profiles
- Asteel Pharma Inc.
- Bharat Biotech Ltd.
- Eli Lilly and Co.
- GE Healthcare
- Glaxosmithkline PLC.
- Indian Immunologicals Ltd.
- Merck & Co.
- Pfizer Inc.
- Roche Diagnostics GMBH
- Serum Institute of India Pvt. Ltd.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
0 Comments